HOLX Hologic

Q2 2025 10-Q

Filed: Jul 31, 2025Period ending Jun 28, 2025

Health Care

X-Ray Apparatus & Tubes & Related Irradiation ApparatusSEC EDGAR

Hologic (HOLX) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Jul 31, 2025 for the fiscal period ending Jun 28, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Risk Factors

• No newly added risk factors disclosed this quarter
• Most materially updated risk: potential material impacts from inaccurate estimates in revenue recognition, asset valuation, and goodwill impairments due to changing assumptions

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.0B

▲ +1.2% YoY▲ +1.8% QoQ

Net Income

$195M

▲ +0.2% YoY▲ +1220.1% QoQ

Net Margin

19.0%

▼ -19bp YoY▲ +2077bp QoQ

Source: XBRL data from Hologic Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Hologic Quarterly Reports

Q4 2025 10-Q

Q1 2025 10-Q

Get deeper insights on Hologic

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.